:max_bytes(133120)/d1qcnx2r3xkirq.cloudfront.net/pop/pop-rssapp-time-com-2b6efce9/b4e23c0af46a6c90157e43c73289931f_wm.png)
What to Know About Trump’s New Executive Order on Psychedelic Drugs
Summary: President Trump signed a new order to speed up medical research on psychedelic drugs like MDMA and psilocybin. These drugs might help treat severe depression and PTSD. The idea came from talks with podcast host Joe Rogan about a drug called ibogaine. While ibogaine comes from an African shrub and can be dangerous for the heart, the government is offering $50 million to help states study these treatments safely. This is a huge change from the past when presidents fought a strict "war on drugs."
For more details, see rssapp-time-com at time.com/article/2026/04/21/trump-psychedelics-executive-order-what-to-know/ (opens in new tab)
Tags
Lysergic Acid Diethylamide
N-Methyl-3,4-methylenedioxyamphetamine
Hallucinogens
State Government